VGLS DD Below is some DD as to why I kept buying VGLS. After the RS I ended up with 27,500 shares and I believe we are about to see a massive explosion once the merger closes. ——
In simple terms: this document is the Florida corporate filing (Articles of Incorporation / amendment record) for the company now called SB Technology Holdings, Inc., which is the entity that replaced or renamed the old OTC shell company VG Life Sciences (VGLS). It shows the official state registration details—company name, address (447 Broadway in New York), officers, and filing history—and it confirms that the shell company legally changed its structure and name to SB Technology Holdings, Inc. as part of the corporate reorganization process that typically happens before a reverse merger or new operating company takes over the public shell. —————— On that exact day 08/29/2025 SandBoxAQ filed this with the SEC. Pay particular attention to point 7 (where it shows the 08/29 date of sale) 10 (where it shows why - merger / acquisition) and point 12 (where it shows the amount they paid; just over $6MM)
It is a Florida filing registering SB Technology, Inc. as a foreign corporation, which means the company was incorporated in another state but is obtaining permission to legally conduct business in Florida. These filings typically list the company’s home jurisdiction, officers, registered agent, and principal business address. It’s worth noting that the principal address listed in the filing is the same New York address used by VGLS — 447 Broadway — which is the same address that appears in earlier corporate documents connected to the VGLS shell. ——- THE NAMES It is also worth noting that two closely related entities appear in the filings: SB Technology, Inc. and SB Technology Holdings, Inc. In corporate structures, it is common for companies to organize themselves with a holding company and one or more operating companies. The holding company typically owns the equity of the operating subsidiaries and serves as the parent entity that holds intellectual property, strategic assets, and investor ownership, while the operating company conducts the day-to-day business activities such as contracts, employees, and revenue generation. This type of structure is widely used because it allows companies to separate ownership, investment, and governance (at the holding company level) from operational risk and commercial activity (at the operating company level). As a result, the presence of both SB Technology Holdings, Inc. and SB Technology, Inc. is consistent with a typical corporate structure in which the holding company sits at the top and the operating company functions as the active business subsidiary ———WHY WOULD A COMPANY LIKE SANDBOXAQ REVERSE MERGE WITH AN OTC PINK COMPANY? PATENTS
It relates to the intellectual property already inside the shell. VGLS historically developed and patented technologies around oxidative stress, viral replication, and bio-computational approaches to drug discovery, which involve modeling biological systems and molecular interactions. Those themes overlap conceptually with what SandboxAQ does today—using AI and advanced computational techniques to simulate molecules, accelerate drug discovery, and model complex biological processes. In theory, if a larger technology company were interested in those patents or the underlying research direction, acquiring or merging with the public entity that owns them could provide both control of the intellectual property and an existing public-market vehicle. In other words, the relevance would come from the potential alignment between VGLS’s legacy biomedical patents and SandboxAQ’s AI-driven pharmaceutical and molecular simulation work
Market Data 
Markets 
AI
